Cerebras Systems Inc., the AI chipmaker that raised $548 million in its initial public offering, saw its stock plummet after-hours following its first earnings report. The company reported a first-quarter revenue of $43.8 million, beating analyst expectations of $36.8 million.
The good news stopped there, however, as Cerebras’ net loss widened to $134.4 million from $92.2 million in the same period last year. This led to a earnings per share (EPS) of -$2.21, falling short of the -$1.92 forecasted by Wall Street.
What Went Wrong?
According to analysts, Cerebras’ struggles can be attributed to its high research and development (R&D) expenses, which rose by 45% year-over-year. The company’s R&D spending totaled $133.6 million in the first quarter, eating into its already slimmer profit margins.
Affordable AI?
Founded in 2014 by Dan McNalley, a renowned AI researcher, Cerebras aims to make AI more accessible and affordable for enterprises. The company’s flagship product, the Wavescale processor, is designed to be used in high-performance computing clusters and data centers. Despite the mixed results, Cerebras’ management remains bullish on its product roadmap.
What This Means
The stock price drop may dampen investor enthusiasm for AI chipmakers, at least in the short term. However, it doesn’t necessarily spell doom for the industry as a whole. In reality, the challenges faced by Cerebras are not unique and may be a sign of the growing pains associated with scaling up AI innovation. For real people, it means that AI’s potential to transform industries will continue to be a work in progress – but that doesn’t mean it won’t get there, eventually.
